Pharmanutra S.p.A. (BIT: PHN)

Market Cap	522.67M
Revenue (ttm)	113.67M
Net Income (ttm)	16.27M
Shares Out	9.61M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	26.35
Dividend	0.85 (1.53%)
Ex-Dividend Date	n/a

Volume	5,231
Open	56.00
Previous Close	55.70
Day's Range	55.40 - 56.60
52-Week Range	44.85 - 63.50
Beta	0.31
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. It also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. The company’s products primarily include SiderAL, SiderAL Forte, SiderAL...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 105
• Stock Exchange: Borsa Italiana
• Ticker Symbol: PHN

Financial Performance

In 2023, Pharmanutra's revenue was 101.03 million, an increase of 21.64% compared to the previous year's 83.06 million. Earnings were 12.83 million, a decrease of -14.73%.